Skip to main content
Premium Trial:

Request an Annual Quote

Agendia Closes Second Financing Round; Undisclosed Amount Higher Than Series A

NEW YORK, Oct. 11 (GenomeWeb News) - Dutch diagnostics firm Agendia has closed a second round of financing worth "double-digit" millions of dollars to accelerate the development of microarray-based late-stage products into diagnostic tests, the company said today.

 

An Agendia spokesperson declined to provide a specific amount, but said that the financing improved upon the company's Series A round, which closed in March 2004.

 

The financing round was led by existing investors Gilde, AXA, and GLSV, and new investor Van Herk Group.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.